Board of Directors of the Fredun Pharmaceuticals Limited at its meeting held on May 16, 2022 approved the Recommended Final Dividend at 7% per Equity Share having face value of INR 10/- each for the Financial Year 2021-22; subject to the approval of the shareholders at the upcoming 35th Annual General Meeting of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
793.7 INR | -0.03% | -5.47% | -8.64% |
10/05 | Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24 | CI |
08/05 | Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9% | MT |
1st Jan change | Capi. | |
---|---|---|
-8.64% | 44.69M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- FREDUN6 Stock
- News Fredun Pharmaceuticals Limited
- Fredun Pharmaceuticals Limited Approves Dividend for the Financial Year 2021-22